Loading market dashboard
Cigna Corporation
CIHealthcareNYSEUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges, including OTC networks. In addition to the primary list that yields 4.2%, we present two other groups of five DGI stocks each, from moderate to high yields of up to 8%.
Health insurers are running higher in Thursday afternoon trading after a wave of bullish Wall Street analyst notes on the managed-care sector, centered on UnitedHealth, citing softer medical cost and utilization trends plus potential AI efficiency upside.
Aging demographics, sound Medicare premiums, digital healthcare adoption and increased M&A activity are likely to drive the performance of the Zacks Medical-HMO industry players. UNH, CI, HUM, CNC and MOH are poised to benefit from favorable industry prospects.
CNBC's Becky Quick reports on the latest news.
Health insurer Cigna will stop covering GLP-1 weight-loss drugs including Novo Nordisk's Wegovy and Eli Lilly's Zepbound in its employee health plan effective July 1, according to materials viewed by Reuters on Tuesday.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
CRANBURY, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Cigna Healthcare® has selected MJH Life Sciences® as a recipient of its 2025 gold-level Healthy Workforce Designation for demonstrating a strong commitment to improving the health and vitality of its employees through a workplace well-being program.
Pre-Market Stock Futures: Futures are trading higher as investors return to a holiday-shortened trading week after a record-setting Friday, when the S&P 500, which posted its eighth straight weekly gain, and the Dow Jones Industrial Average both posted new all-time highs, closing at 7,473 and 50,579, respectively. Not to be left behind, the Nasdaq closed... Here Are Tuesday's Top Wall Street Analyst Research Calls: Albemarle, Booz Allen Hamilton, Cigna, DT Midstream, GE Vernova, Intel, Okta, Travelers, Occidental Petroleum, and More
Pre-Market Stock Futures: Futures are trading higher on the heels of the third straight day of stock declines, and there is growing apprehension that yields will go even higher and that inflation may as well. All of the major indices finished Tuesday lower, and with Q1 earnings all but over and the incoming economic data... Here Are Wednesday's Top Wall Street Analyst Research Calls: BJ's Wholesale Club, Centene, Cigna, Crown Castle, ETSY, Franco-Nevada, Humana, Ovintiv, X-Energy, and More
Pharmacy benefit managers (PBMs) sit at the chokepoint of U.S. drug distribution.
Cigna Group is reiterated as a "Buy," driven by strong Q1 2026 results, raised guidance, and sustained business momentum. CI's pharmacy and behavioral health segments are fueling revenue growth, while divestitures and PBM reform temporarily temper 2026 earnings. Shares trade at a 25% discount to a $377 fair value estimate, offering potential 15% annual total returns through 2031.
CI trades below the industry's forward P/E as Evernorth's growth, earnings beats and shareholder returns support its long-term outlook.
The Cigna Group (CI) Presents at Bank of America Global Healthcare Conference 2026 Transcript
BLOOMFIELD, Conn., May 13, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced that Brian Evanko, President and Chief Operating Officer of The Cigna Group, will present at the BofA Securities 2026 Health Care Conference today, May 13, 2026, in Las Vegas, NV.
On May 12, 2026, The Cigna Group (CI) shares rose 3.6% to a current price of $298.49. The stock has experienced a 52-week range, with a high of $338.89 and a lo
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Solid first-quarter results from major insurers like UnitedHealth, Elevance, Cigna and Humana have helped lift investor sentiment, even as insurers continue to grapple with higher medical costs. But analysts caution that insurers have incomplete data on medical costs in the first quarter due to a lag in claims processing, which sets up the second quarter as the real proving ground.
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges, including OTC networks. In addition to the primary list that yields 4.74%, we present two other groups of five DGI stocks each, from moderate to high yields of up to 8%.
Cigna Group (CI) delivers robust quarterly results, with adjusted EPS up 16% and revenue up 5%, reinforcing core business resilience. CI raises 2026 adjusted EPS outlook to at least $30.35, reflecting confidence in margin expansion and ongoing shareholder returns via buybacks and dividends. Valuation remains compelling at 9.6x forward earnings, with strong cash flow, disciplined capital deployment, and a solid balance sheet supporting the Buy rating.
CI beats Q1 EPS estimates as Evernorth revenues jump 9% despite rising pharmacy costs; 2026 EPS outlook lifted to at least $30.35.
The Cigna Group (NYSE:CI) shares are marginally down on Thursday as the company reported first-quarter results.
The Cigna Group (CI) Q1 2026 Earnings Call Transcript
While the top- and bottom-line numbers for Cigna (CI) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Cigna Group will exit the Affordable Care Act market next year, citing an effort to focus on other lines of business.
The Cigna Group Thursday confirmed plans to exit the individual health insurance business also known as Obamacare next year, leaving about 369,00 health plan members in 11 states looking for new coverage in 2027.
Cigna (CI) came out with quarterly earnings of $7.79 per share, beating the Zacks Consensus Estimate of $7.62 per share. This compares to earnings of $6.74 per share a year ago.
Cigna Group logged higher profit and revenue in its latest quarter as its pharmacy-benefit business Evernorth continued to grow.
Cigna slightly raised its annual adjusted profit forecast on Thursday after beating first-quarter earnings estimates, helped by strength in its health services unit and as medical costs came in lower than expected.
Total revenues for the first quarter 2026 increased 5% to $68.5 billion Shareholders' net income for the first quarter 2026 was $1.7 billion, or $6.26 per share Adjusted income from operations1 for the first quarter 2026 was $2.1 billion, or $7.79 per share 2026 outlook2 for adjusted income from operations1,2 increased to at least $30.35 per share2 BLOOMFIELD, Conn., April 30, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) today reported first quarter 2026 results, reflecting growth across its diversified portfolio of businesses.
Comerica Bank cut its position in Cigna Group (NYSE: CI) by 14.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 50,658 shares of the health services provider's stock after selling 8,758 shares during the quarter. Comerica Bank's holdings in Cigna Group
NEW YORK--(BUSINESS WIRE)--Cigna Healthcare® has selected Baron Capital as a recipient of their 2025 gold level Healthy Workforce Designation for demonstrating a strong commitment to improving the health and vitality of its employees through a workplace well-being program. Baron Capital's approach to employee health and wellness continues to grow and adapt to the evolving needs of its workforce. Through expanded access to preventive care, education, and supportive resources, the Firm aims to ma.
Get a deeper insight into the potential performance of Cigna (CI) for the quarter ended March 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
CI approaches Q1 results with strong pharmacy growth but a steep premium drop, as estimates point to mixed year-over-year performance.
BLOOMFIELD, Conn., April 24, 2026 /PRNewswire/ -- The Cigna Group (NYSE:CI), a global health company, today joined leading health plans in a commitment to standardize electronic prior authorization submission requirements for commonly reviewed medical services, a step that will accelerate patients' access to care and simplify administrative work for providers and their teams.
Cigna (CI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
BLOOMFIELD, Conn., April 22, 2026 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.56 per share of its common stock, payable on June 18, 2026, to shareholders of record as of the close of business on June 4, 2026.
Davidson Investment Advisors decreased its holdings in Cigna Group (NYSE: CI) by 7.1% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 61,964 shares of the health services provider's stock after selling 4,755 shares during the quarter. Davidson
Assetmark Inc. reduced its stake in shares of Cigna Group (NYSE: CI) by 3.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 59,699 shares of the health services provider's stock after selling 2,110 shares during the quarter. Assetmark Inc.'s holdings
Nonprofits can apply through May 15 for two-year grants supporting community–led solutions to reduce barriers to health LEARN MORE AND APPLY HERE MEMPHIS, Tenn., April 16, 2026 /PRNewswire/ -- Building on years of community investment and employee volunteerism across Tennessee, The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE: CI), today announced the expansion of its Impact Fund to Memphis.
Customers rank myCigna highest for digital satisfaction as Cigna Healthcare continues to invest in AI-powered, personalized tools that make managing health care coverage simpler and more reliable BLOOMFIELD, Conn., April 15, 2026 /PRNewswire/ -- Cigna Healthcare®, the health benefits division of The Cigna Group (NYSE: CI), ranked No.
Flagship Harbor Advisors LLC raised its holdings in shares of Cigna Group (NYSE: CI) by 45.5% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,990 shares of the health services provider's stock after acquiring an additional 1,872 shares during
Cigna Group remains a Buy, with catalysts for double-digit adjusted income per share growth resuming in 2027 and beyond. CI's pharmacy segment, biosimilar adoption, behavioral health expansion, and aggressive share buybacks drive both topline and margin growth. Shares trade at an 8.5x forward P/E, a 29% discount to fair value, supporting a projected 17% annual total return through 2031.
Banque Pictet and Cie SA increased its position in shares of Cigna Group (NYSE: CI) by 40.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 25,216 shares of the health services provider's stock after purchasing an additional 7,204 shares during
Cigna (CI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
BLOOMFIELD, Conn., April 2, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its first quarter 2026 financial results on Thursday, April 30, 2026, and will host a conference call the same day.
Exchange Traded Concepts LLC boosted its holdings in Cigna Group (NYSE: CI) by 31.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,539 shares of the health services provider's stock after buying an additional 2,055 shares during
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
apricus wealth LLC lifted its stake in shares of Cigna Group (NYSE: CI) by 715.9% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,505 shares of the health services provider's stock after buying an additional 8,340 shares during the period. apricus wealth
UBS analysts have outlined a set of high-conviction healthcare ideas where they believed the market was underappreciating earnings durability and the scale of upcoming catalysts, focusing on stocks backed by differentiated views and proprietary insights. In biotechnology, they identified Cogent Biosciences (NASDAQ:COGT) as their top pick, arguing the company offered scarcity value as a SMID-cap advancing two late-stage, potentially blockbuster assets.
Pallas Capital Advisors LLC raised its position in Cigna Group (NYSE: CI) by 133.1% during the undefined quarter, according to its most recent filing with the SEC. The institutional investor owned 4,774 shares of the health services provider's stock after acquiring an additional 2,726 shares during the period. Pallas Capital Advisors LLC's holdings
With grant funding, more than 20 nonprofit partners expanded access to stable housing and wraparound support services to support veteran communities in 10 states. Read the new Impact Report with outcomes in Arizona, Connecticut, Florida, Georgia, Illinois, Missouri, New Jersey, Pennsylvania, Tennessee and Texas.
CIBC Bancorp USA Inc. purchased a new stake in Cigna Group (NYSE: CI) in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 36,834 shares of the health services provider's stock, valued at approximately $10,617,000. Several other large investors have also modified their
Danske Bank A S bought a new position in Cigna Group (NYSE: CI) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 179,920 shares of the health services provider's stock, valued at approximately $51,862,000. Danske Bank A S owned approximately
Banco Bilbao Vizcaya Argentaria S.A. lifted its position in shares of Cigna Group (NYSE: CI) by 13.5% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 34,114 shares of the health services provider's stock after purchasing an additional 4,066 shares
California Public Employees Retirement System trimmed its position in Cigna Group (NYSE: CI) by 9.0% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 690,200 shares of the health services provider's stock after selling 67,990 shares during the quarter. California Public
Ameriprise Financial Inc. boosted its position in Cigna Group (NYSE: CI) by 54.5% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,136,311 shares of the health services provider's stock after acquiring an additional 753,865 shares during the period. Ameriprise
CI trades below industry P/E as Evernorth growth, steady earnings beats and buybacks support outlook, though rising medical costs and debt remain key risks.
